{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:08:13Z","timestamp":1792382893401,"version":"4.4.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T00:00:00Z","timestamp":1622937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.kint.2021.04.043","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T11:06:42Z","timestamp":1622891202000},"page":"546-558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8274-6356","authenticated-orcid":false,"given":"Mathias","family":"Haarhaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-4321","authenticated-orcid":false,"given":"Pieter","family":"Evenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2021.04.043_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2021.04.043_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11255-009-9702-2","article-title":"Bone mineral density and parathyroid function in patients on maintenance hemodialysis","volume":"43","author":"Ambrus","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib3","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","article-title":"Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0272-6386(96)90461-8","article-title":"Prevalence and risk factors for osteopenia in dialysis patients","volume":"28","author":"Stein","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.04.043_bib5","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/ndt\/14.8.1922","article-title":"Risk factors for reduced bone density in haemodialysis patients","volume":"14","author":"Taal","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.04.043_bib6","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/ndt\/gfg403","article-title":"Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients","volume":"18","author":"Ure\u00f1a","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.04.043_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D","volume":"36","author":"Evenepoel","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.04.043_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.afos.2019.05.001","article-title":"Diabetes and bone","volume":"5","author":"Hygum","year":"2019","journal-title":"Osteoporos Sarcopenia"},{"key":"10.1016\/j.kint.2021.04.043_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11926-019-0836-7","article-title":"Osteoporosis pathophysiology, epidemiology, and screening in rheumatoid arthritis","volume":"21","author":"Adami","year":"2019","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.kint.2021.04.043_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0889-8529(02)00062-2","article-title":"Secondary osteoporosis","volume":"32","author":"Stein","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.kint.2021.04.043_bib12","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00198-014-2813-3","article-title":"Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis","volume":"26","author":"Bucur","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2021.04.043_bib14","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00198-005-1903-7","article-title":"In elderly men and women treated for osteoporosis a low creatinine clearance of\u00a0<65 ml\/min is a risk factor for falls and fractures","volume":"16","author":"Dukas","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2021.04.043_bib15","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2215\/CJN.09500916","article-title":"Fractures in patients with CKD: time for action","volume":"11","author":"Moe","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib16","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib17","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2021.04.043_bib18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM198209163071202","article-title":"The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy","volume":"307","author":"Ott","year":"1982","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 3","key":"10.1016\/j.kint.2021.04.043_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/11.supp3.111","article-title":"Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients","volume":"11","author":"Monier-Faugere","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.04.043_bib23","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1681\/ASN.2007050622","article-title":"Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD","volume":"19","author":"London","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1359\/jbmr.090735","article-title":"Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment","volume":"25","author":"Tomiyama","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib25","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1053\/j.ajkd.2008.06.024","article-title":"Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study","volume":"52","author":"Barreto","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.04.043_bib26","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis","volume":"67","author":"Sprague","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.04.043_bib28","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/pds.4045","article-title":"Denosumab-associated hypocalcaemia: incidence, severity and patient characteristics in a tertiary hospital setting","volume":"25","author":"Huynh","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.kint.2021.04.043_bib29","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.2008.60","article-title":"Adynamic bone in patients with chronic kidney disease","volume":"73","author":"Andress","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","article-title":"Adynamic bone disease: from bone to vessels in chronic kidney disease","volume":"34","author":"Bover","year":"2014","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","article-title":"Changing bone patterns with progression of chronic kidney disease","volume":"89","author":"Dr\u00fceke","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib32","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1523-1755.1998.00080.x","article-title":"Hypokinetic azotemic osteodystrophy","volume":"54","author":"Cannata-And\u00eda","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10157-016-1369-2","article-title":"Management of secondary hyperparathyroidism: how and why?","volume":"21","author":"Komaba","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1053\/j.ajkd.2015.11.028","article-title":"PTH and\/or bone histology: are we still waiting for a verdict from the CKD-MBD grand jury?","volume":"67","author":"Covic","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.04.043_bib35","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.kint.2016.12.029","article-title":"The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease","volume":"91","author":"Graciolli","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib36","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/\u03b2-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bone.2011.11.016","article-title":"TGF-\u03b2 regulates sclerostin expression via the ECR5 enhancer","volume":"50","author":"Loots","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.kint.2021.04.043_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.kint.2017.06.016","article-title":"The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease","volume":"93","author":"Williams","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","article-title":"Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease","volume":"90","author":"Carrillo-Lopez","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00223-020-00803-2","article-title":"Role of the RANK\/RANKL\/OPG and Wnt\/\u03b2-catenin systems in CKD bone and cardiovascular disorders","volume":"108","author":"Carrillo-L\u00f3pez","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.kint.2021.04.043_bib41","first-page":"100","article-title":"Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients","volume":"21","author":"Feroze","year":"2011","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.kint.2021.04.043_bib42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00198-018-4774-4","article-title":"Association between malnutrition-inflammation score and risk of subsequent self-reported bone fractures in prevalent kidney transplant recipients","volume":"30","author":"Gaipov","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2021.04.043_bib43","doi-asserted-by":"crossref","first-page":"c211","DOI":"10.1159\/000321642","article-title":"Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort","volume":"118","author":"Jean","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.kint.2021.04.043_bib44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00000441-199906000-00002","article-title":"Modulation of parathyroid cell function by calcium ion in health and uremia","volume":"317","author":"Akizawa","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.kint.2021.04.043_bib45","first-page":"198","article-title":"Serum albumin levels, an additional factor implicated in hyperparathyroidism outcome in peritoneal dialysis: a prospective study with paired bone biopsies","volume":"22","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2006","journal-title":"Adv Perit Dial"},{"key":"10.1016\/j.kint.2021.04.043_bib46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00041552-199707000-00005","article-title":"Role of cytokines in renal osteodystrophy","volume":"6","author":"Monier-Faugere","year":"1997","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2021.04.043_bib47","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/ajkd.2001.20574","article-title":"Cultures of human osteoblastic cells from dialysis patients: influence of bone turnover rate on in\u00a0vitro selection of interleukin-6 and osteoblastic cell makers","volume":"37","author":"S\u00e1nchez","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.04.043_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1020146023812","article-title":"Interleukin-6 induced suppression of bovine parathyroid hormone secretion","volume":"19","author":"Carlstedt","year":"1999","journal-title":"Biosci Rep"},{"key":"10.1016\/j.kint.2021.04.043_bib49","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1006\/bbrc.1997.7207","article-title":"Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in\u00a0vitro is associated with an up-regulation of the calcium-sensing receptor mRNA","volume":"238","author":"Nielsen","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.kint.2021.04.043_bib50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00198-016-3769-2","article-title":"Biologic therapies and bone loss in rheumatoid arthritis","volume":"28","author":"Zerbini","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2021.04.043_bib51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.semarthrit.2012.01.004","article-title":"IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522)","volume":"42","author":"Karsdal","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.kint.2021.04.043_bib52","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00774-009-0055-9","article-title":"The effect of risedronate treatment on serum cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study","volume":"27","author":"Dundar","year":"2009","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"suppl 3","key":"10.1016\/j.kint.2021.04.043_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/11.supp3.29","article-title":"The aplastic form of renal osteodystrophy","volume":"11","author":"Sherrard","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.04.043_bib54","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00198-015-3258-z","article-title":"Bone histomorphometry in diabetes mellitus","volume":"26","author":"Moreira","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2021.04.043_bib55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.kint.2021.04.043_bib56","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11914-016-0329-9","article-title":"Effects of type 1 diabetes on osteoblasts, osteocytes, and osteoclasts","volume":"14","author":"Kalaitzoglou","year":"2016","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.kint.2021.04.043_bib57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13098-017-0278-1","article-title":"The impact of type 2 diabetes on bone metabolism","volume":"9","author":"Sanches","year":"2017","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.kint.2021.04.043_bib58","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Nii-Kono","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cca.2018.05.057","article-title":"Effect of uremic toxin-indoxyl sulfate on the skeletal system","volume":"484","author":"Liu","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.kint.2021.04.043_bib60","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/ndt\/gfl311","article-title":"Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats","volume":"21","author":"Iwasaki","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.04.043_bib61","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality\u2014the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2021.04.043_bib62","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jbmr.5650050402","article-title":"Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels","volume":"5","author":"Eriksen","year":"1990","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib63","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/sj.ki.5000311","article-title":"Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem","volume":"69","author":"Barreto","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib64","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bone.2007.10.010","article-title":"Decreased bone turnover with balanced resorption and formation prevent cortical bone loss during disuse (hibernation) in grizzly bears (Ursus arctos horribilis)","volume":"42","author":"McGee","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.kint.2021.04.043_bib65","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.bone.2009.08.011","article-title":"Grizzly bears (Ursus arctos horribilis) and black bears (Ursus americanus) prevent trabecular bone loss during disuse (hibernation)","volume":"45","author":"McGee-Lawrence","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.kint.2021.04.043_bib66","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1242\/jeb.120725","article-title":"Suppressed bone remodeling in black bears conserves energy and bone mass during hibernation","volume":"218","author":"McGee-Lawrence","year":"2015","journal-title":"J\u00a0Exp Biol"},{"key":"10.1016\/j.kint.2021.04.043_bib67","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2014a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.04.043_bib68","doi-asserted-by":"crossref","first-page":"e2903","DOI":"10.1210\/clinem\/dgaa317","article-title":"Biomarkers of bone turnover identify subsets of chronic kidney disease patients at higher risk for fracture","volume":"105","author":"Hughes-Austin","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2021.04.043_bib69","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","article-title":"Evidence for abnormal calcium homeostasis in patients with adynamic bone disease","volume":"46","author":"Kurz","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib70","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.2009060640","article-title":"Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification","volume":"21","author":"Shroff","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib71","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib72","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1681\/ASN.2015030268","article-title":"Reduction of dialysate calcium level reduces progression of coronary artery calcification and improves low bone turnover in patients on hemodialysis","volume":"27","author":"Ok","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib73","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/ndt\/gfq491","article-title":"The link between bone and coronary calcifications in CKD-5 patients on haemodialysis","volume":"26","author":"Asci","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.04.043_bib74","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"382","author":"Jamal","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2021.04.043_bib75","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamainternmed.2019.0045","article-title":"Cardiovascular outcomes of calcium-free vs calcium-based phosphate binders in patients 65 years or older with end-stage renal disease requiring hemodialysis","volume":"179","author":"Spoendlin","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.kint.2021.04.043_bib76","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.kint.2015.12.001","article-title":"Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients","volume":"89","author":"Merle","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib77","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12882-016-0365-9","article-title":"Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients","volume":"17","author":"Jean","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib78","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.2169\/internalmedicine.54.4946","article-title":"Rapid progression of vascular and soft tissue calcification while being managed for severe and persistent hypocalcemia induced by denosumab treatment in a patient with multiple myeloma and chronic kidney disease","volume":"54","author":"Ueki","year":"2015","journal-title":"Intern Med"},{"key":"10.1016\/j.kint.2021.04.043_bib79","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jbmr.3676","article-title":"Effects of denosumab and alendronate on bone health and vascular function in hemodialysis patients: a randomized, controlled trial","volume":"34","author":"Iseri","year":"2019","journal-title":"J Bone Miner. Res"},{"key":"10.1016\/j.kint.2021.04.043_bib80","first-page":"437","article-title":"Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis","volume":"13","author":"Gerakis","year":"2000","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib81","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/039139880302600304","article-title":"Radial bone mineral density in hemodialysis patients with adynamic bone disease","volume":"26","author":"Nakashima","year":"2003","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.kint.2021.04.043_bib82","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1681\/ASN.2017050584","article-title":"Diagnostic accuracy of biomarkers and imaging for bone turnover in renal osteodystrophy","volume":"29","author":"Salam","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib83","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12882-017-0692-5","article-title":"Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study","volume":"18","author":"J\u00f8rgensen","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib84","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jbmr.2361","article-title":"Relationship between pretreatment rate of bone loss and bone density response to once-yearly ZOL: HORIZON-PFT extension study","volume":"30","author":"Eastell","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2014.07.037","article-title":"Development, validation and characterization of a novel mouse model of adynamic bone disease (ABD)","volume":"68","author":"Ng","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.kint.2021.04.043_bib86","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1073\/pnas.1704460114","article-title":"Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance","volume":"114","author":"Lloyd","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2021.04.043_bib87","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/jbmr.2702","article-title":"Adynamic bone decreases bone toughness during aging by affecting mineral and matrix","volume":"31","author":"Ng","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10182","article-title":"Persistent activation of calcium-sensing receptor suppresses bone turnover, increases microcracks, and decreases bone strength","volume":"3","author":"Dong","year":"2019","journal-title":"JBMR Plus"},{"key":"10.1016\/j.kint.2021.04.043_bib89","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.04.043_bib90","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2215\/CJN.09280915","article-title":"Bone parameters and risk of hip and femur fractures in patients on hemodialysis","volume":"11","author":"Fishbane","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib91","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bone.2018.11.012","article-title":"Skeletal manifestations of hypoparathyroidism","volume":"120","author":"Rubin","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.kint.2021.04.043_bib92","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1681\/ASN.2007010022","article-title":"Fracture risk after parathyroidectomy among chronic hemodialysis patients","volume":"18","author":"Rudser","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"85","key":"10.1016\/j.kint.2021.04.043_bib93","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1046\/j.1523-1755.63.s85.13.x","article-title":"The renal osteodystrophy pattern in Brazil and Uruguay: an overview","author":"Ara\u00fajo","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2021.04.043_bib94","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrneph.2017.60","article-title":"Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD","volume":"13","author":"Haarhaus","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib95","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","article-title":"A\u00a0higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan","volume":"29","author":"Maruyama","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.04.043_bib96","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2215\/CJN.06091108","article-title":"Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients","volume":"4","author":"Shantouf","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib97","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib98","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.bone.2011.01.016","article-title":"Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD)","volume":"48","author":"Manghat","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.kint.2021.04.043_bib99","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1359\/jbmr.080610","article-title":"Bone markers predict cardiovascular events in chronic kidney disease","volume":"23","author":"Fahrleitner-Pammer","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib100","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","article-title":"Survival following parathyroidectomy among United States dialysis patients","volume":"66","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib101","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/j.ajkd.2005.04.035","article-title":"Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD","volume":"46","author":"Bleyer","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.04.043_bib102","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MNH.0000000000000326","article-title":"Resurgence of parathyroidectomy: evidence and outcomes","volume":"26","author":"Komaba","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2021.04.043_bib103","doi-asserted-by":"crossref","first-page":"c80","DOI":"10.1159\/000151722","article-title":"Calcium requirements after parathyroidectomy in patients with refractory secondary hyperparathyroidism","volume":"110","author":"Viaene","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.kint.2021.04.043_bib104","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/jbmr.2043","article-title":"RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk","volume":"29","author":"Samelson","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00198-004-1662-x","article-title":"Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women","volume":"16","author":"Tank\u00f3","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2021.04.043_bib106","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.ajkd.2009.12.039","article-title":"Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial","volume":"56","author":"Toussaint","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.04.043_bib107","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0272-6386(04)00937-0","article-title":"Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis","volume":"44","author":"Nitta","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.04.043_bib108","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00198-020-05391-3","article-title":"Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: a pilot study","volume":"31","author":"Chen","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2021.04.043_bib109","doi-asserted-by":"crossref","first-page":"115518","DOI":"10.1016\/j.bone.2020.115518","article-title":"Fifty years of bisphosphonates: what are their mechanical effects on bone?","volume":"138","author":"Burr","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.kint.2021.04.043_bib110","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2021.04.043_bib111","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1210\/jc.2017-02669","article-title":"Effects of long-term denosumab on bone histomorphometry and mineralization in women with postmenopausal osteoporosis","volume":"103","author":"Dempster","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2021.04.043_bib112","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.kint.2018.12.015","article-title":"Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration","volume":"95","author":"D\u00edaz-Tocados","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib113","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ki.2008.242","article-title":"Bone formation by minimodeling is more active than remodeling after parathyroidectomy","volume":"74","author":"Yajima","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.04.043_bib114","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3390\/nu10091164","article-title":"Association of anabolic effect of calcitriol with osteoclast-derived Wnt 10b secretion","volume":"10","author":"Lu","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.kint.2021.04.043_bib115","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/(SICI)1097-0185(199712)249:4<458::AID-AR5>3.0.CO;2-N","article-title":"Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on the cancellous bone formed before, during, and after treatment","volume":"249","author":"Pataki","year":"1997","journal-title":"Anat Rec"},{"key":"10.1016\/j.kint.2021.04.043_bib116","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2016.06.039","article-title":"Bisphosphonates for cardiovascular risk reduction: a systematic review and meta-analysis","volume":"252","author":"Kranenburg","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.kint.2021.04.043_bib117","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/jbmr.3448","article-title":"Association of alendronate and risk of cardiovascular events in patients with hip fracture","volume":"33","author":"Sing","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib118","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1210\/jc.2014-1154","article-title":"An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis","volume":"99","author":"Chen","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2021.04.043_bib119","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10067-016-3447-y","article-title":"Young patients and those with a low eGFR benefitted more from denosumab therapy in femoral neck bone mineral density","volume":"36","author":"Cheng","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.kint.2021.04.043_bib120","first-page":"271","article-title":"Safety and efficacy of denosumab in osteoporotic hemodialysed patients","volume":"30","author":"Festuccia","year":"2017","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib121","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/j.ajkd.2015.03.012","article-title":"Denosumab for low bone mass in hemodialysis patients: a noncontrolled trial","volume":"66","author":"Hiramatsu","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.04.043_bib122","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/s41598-020-59143-8","article-title":"Denosumab for dialysis patients with osteoporosis: a cohort study","volume":"10","author":"Kunizawa","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2021.04.043_bib123","doi-asserted-by":"crossref","first-page":"6218129","DOI":"10.1155\/2017\/6218129","article-title":"Denosumab for male hemodialysis patients with low bone mineral density: a case-control study","volume":"2017","author":"Takami","year":"2017","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib124","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00198-018-4533-6","article-title":"Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies","volume":"29","author":"Thongprayoon","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2021.04.043_bib125","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1210\/jc.2015-1259","article-title":"Effects of denosumab and calcitriol on severe secondary hyperparathyroidism in dialysis patients with low bone mass","volume":"100","author":"Chen","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2021.04.043_bib126","doi-asserted-by":"crossref","unstructured":"Hiramatsu R, Ubara Y, Sawa N, Sakai A. Hypocalcemia and bone mineral changes in hemodialysis patients with low bone mass treated with denosumab: a 2-year observational study [e-pub ahead of print]. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfaa359. Accessed June 29, 2021.","DOI":"10.1093\/ndt\/gfaa359"},{"key":"10.1016\/j.kint.2021.04.043_bib127","first-page":"510","article-title":"Treatment of reduced bone density with ibandronate in dialysis patients","volume":"21","author":"Bergner","year":"2008","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib128","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000341864","article-title":"Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients: a pilot study","volume":"36","author":"Mitsopoulos","year":"2012","journal-title":"Am J Nephrol"},{"issue":"85","key":"10.1016\/j.kint.2021.04.043_bib129","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1046\/j.1523-1755.63.s85.21.x","article-title":"Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis","author":"Torregrosa","year":"2003","journal-title":"Kidney Int. Suppl"},{"key":"10.1016\/j.kint.2021.04.043_bib130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1440-1797.2005.00436.x","article-title":"Effects of short-term alendronate on bone mineral density in haemodialysis patients","volume":"10","author":"Wetmore","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.kint.2021.04.043_bib131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000380960","article-title":"Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5","volume":"41","author":"Dave","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2021.04.043_bib132","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/jbmr.1613","article-title":"A single-dose study of denosumab in patients with various degrees of renal impairment","volume":"27","author":"Block","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib133","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12020-018-1548-x","article-title":"Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review","volume":"60","author":"Anagnostis","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.kint.2021.04.043_bib134","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.afos.2016.12.001","article-title":"Bone turnover rate and bone formation\/resorption balance during the early stage after switching from a bone resorption inhibitor to denosumab are predictive factors of bone mineral density change","volume":"3","author":"Nakatoh","year":"2017","journal-title":"Osteoporos Sarcopenia"},{"key":"10.1016\/j.kint.2021.04.043_bib135","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/BOR.0000000000000616","article-title":"The evolving role of anabolic therapy in the treatment of osteoporosis","volume":"31","author":"Cosman","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.kint.2021.04.043_bib136","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000316708","article-title":"Treatment of hemodialysis-associated adynamic bone disease with teriparatide (PTH1-34): a pilot study","volume":"33","author":"Cejka","year":"2010","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.kint.2021.04.043_bib137","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00198-015-3377-6","article-title":"Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study","volume":"27","author":"Sumida","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2021.04.043_bib138","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jbmr.3735","article-title":"Bone-forming and antiresorptive effects of romosozumab in postmenopausal women with osteoporosis: bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment","volume":"34","author":"Chavassieux","year":"2019","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib139","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2021.04.043_bib140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1163\/15718093-12341352","article-title":"Off-label prescription of medication","volume":"22","author":"Vrancken","year":"2015","journal-title":"Eur J Health Law"},{"key":"10.1016\/j.kint.2021.04.043_bib141","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00198-015-3335-3","article-title":"Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015","volume":"27","author":"Khan","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2021.04.043_bib142","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00198-019-05112-5","article-title":"Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure","volume":"30","author":"Lo","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2021.04.043_bib143","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jbmr.1719","article-title":"Incidence of atypical nontraumatic diaphyseal fractures of the femur","volume":"27","author":"Dell","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib144","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00198-019-05002-w","article-title":"Fracture risk following intermission of osteoporosis therapy","volume":"30","author":"Dennison","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.kint.2021.04.043_bib145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/dj4040038","article-title":"Current controversies on the pathogenesis of medication-related osteonecrosis of the jaw","volume":"4","author":"Wat","year":"2016","journal-title":"Dent J (Basel)"},{"key":"10.1016\/j.kint.2021.04.043_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib147","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00402-012-1558-8","article-title":"Anti-osteoporosis therapy and fracture healing","volume":"134","author":"Larsson","year":"2014","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.kint.2021.04.043_bib148","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2021.04.043_bib149","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00198-018-04823-5","article-title":"Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis","volume":"30","author":"Naylor","year":"2019","journal-title":"Osteoporos Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253821005676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253821005676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:00:23Z","timestamp":1758762023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253821005676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0085253821005676"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2021.04.043","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2021.04.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}